Acciones Neuropathix, Inc.
Acciones
NPTX
US64132Q1094
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Dean Petkanas
CEO | Chief Executive Officer | 60 | 25/07/18 |
Mark Corrao
DFI | Director of Finance/CFO | 67 | 25/07/18 |
William Kinney
CTO | Chief Tech/Sci/R&D Officer | 66 | 25/07/18 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Robert Malasek
BRD | Director/Board Member | 55 | 20/06/17 |
Timothy Scott
BRD | Director/Board Member | 71 | 25/07/18 |
Dean Petkanas
CEO | Chief Executive Officer | 60 | 25/07/18 |
Varia. 1 de ene. | Capi. | |
---|---|---|
-1,17 % | 102 mil M | |
+2,87 % | 96,09 mil M | |
+2,13 % | 22,28 mil M | |
-14,77 % | 21,4 mil M | |
-8,79 % | 18,14 mil M | |
-39,98 % | 17,02 mil M | |
-13,21 % | 16,09 mil M | |
+8,55 % | 13,83 mil M | |
+35,75 % | 11,97 mil M |